1-20 of 272
neoplasms, second primary
Close
Save search
Sort by
Journal Articles

A Single Arm, Phase II Study of Eltrombopag to Enhance Platelet Count Recovery in Older Patients with Acute Myeloid Leukemia (AML) Undergoing Remission Induction Therapy

Free
Sudipto Mukherjee, MD PhD MPH, Hong Li, Brian P. Hobbs, PhD, Aaron T. Gerds, MD MS, Anjali S. Advani, MD, Hetty E. Carraway, MD MBA, Aziz Nazha, MD, Samjhana Bogati, RN, Eric Parsons, RN, Benjamin Pannell, Matt Kalaycio, MD, Yogenthiran Saunthararajah, MD, Jaroslaw P. Maciejewski, MD PhD, Mikkael A. Sekeres, MD MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 2595.
https://doi.org/10.1182/blood-2019-132178
Published: 2019
Journal Articles

Oral Arsenic Trioxide, ATRA and Ascorbic Acid (AAA) Maintenance Following First Complete Remission in Acute Promyelocytic Leukemia - Long-Term Data and Unique Prognostic Indicators

Free
Harinder Gill, FRCP, FRCPath, Rita Yim, PhD, Cyrus R Kumana, FRCP, Yok-Lam Kwong, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3853.
https://doi.org/10.1182/blood-2019-125185
Published: 2019
Journal Articles

Polatuzumab Vedotin Plus Bendamustine with Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Updated Results of a Phase Ib/II Randomized Study

Free
Laurie H Sehn, MD, Matthew J Matasar, MD, Christopher R. Flowers, MD MS, Manali Kamdar, MD MD, Andrew K McMillan, FRCP, Mark Hertzberg, MD MBBS, PhD, Sarit Assouline, MD, Tae Min Kim, MD PhD, Won Seog Kim, MD PhD, Muhit Ozcan, MD, Brandon Croft, PharmD, Jamie Hirata, PharmD, Ji Cheng, PhD, Grace Ku, MD, Alex F. Herrera, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4081.
https://doi.org/10.1182/blood-2019-123449
Published: 2019
Journal Articles

Lenalidomide and Rituximab (ReRi) As Front Line Chemo-Free Therapy of Elderly Frail Patients with Diffuse Large B-Cells Lymphoma. a Phase II Study of the Fondazione Italiana Linfomi (FIL)

Free
Guido Gini, MD, Monica Tani, Alessandra Tucci, MD, Renato Bassan, MD, Filippo Ballerini, MD, Michela Sampaolo, Francesco Merli, MD, Francesca Re, Attilio Olivieri, Ombretta Annibali, Anna Marina Liberati, Carlo Visco, Annalisa Arcari, MD, Sergio Storti, MD, Alberto Fabbri, MD, Gerardo Musuraca, MD, Vittorio Ruggero Zilioli, MD, M. Christina Cox, MD PhD, Stefano Luminari, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2880.
https://doi.org/10.1182/blood-2019-126568
Published: 2019
Journal Articles

Sustained Overall Survival Benefit of Obinutuzumab Plus Bendamustine Followed By Obinutuzumab Maintenance Compared with Bendamustine Alone in Patients with Rituximab-Refractory Indolent Non-Hodgkin Lymphoma: Final Results of the Gadolin Study

Free
Laurie H Sehn, MD, Marek Trněný, MD, Kamal Bouabdallah, MD, Gregory Dueck, MD, John G. Gribben, MD DSc, P.J. Lugtenburg, MD PhD, Gilles A. Salles, MD PhD, Andrea Knapp, PhD, Tina G Nielsen, MD PhD, Wenxin Liu, PhD, Bruce D. Cheson, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2822.
https://doi.org/10.1182/blood-2019-123422
Published: 2019
Journal Articles

Impact of Previous Cancer Therapy on Outcome of Patients with Multiple Myeloma or Smoldering Disease

Free
Fahrettin Covut, MD, Gayathri Ravi, MD, James Driscoll, MD PhD, Marcos de Lima, MD, Ehsan Malek, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3174.
https://doi.org/10.1182/blood-2019-126059
Published: 2019
Journal Articles

Hispanic and Black Patients with Adult B-Cell Acute Lymphoblastic Leukemia Have a Significantly Worse Survival in the Modern Era - a SEER 2010-2016 Analysis

Free
Nishi Shah, MBBS, MPH, Mohammad Kazemi, Stephen Zachary Peeke, MD, Lizamarie Bachier-rodriguez, R.Alejandro Sica, MD, Noah Kornblum, MD, Ira Braunschweig, MD, Aditi Shastri, MD, Amit Verma, MBBS, Ioannis Mantzaris, MD MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 426.
https://doi.org/10.1182/blood-2019-123168
Published: 2019
Journal Articles

Outcome Among Adolescents and Young Adults with Acute Myeloid Leukemia at Pediatric Versus Adult Centers: A Population-Based Study Using the IMPACT Cohort

Free
Sumit Gupta, MD, Nancy Baxter, MD PhD, Jason Pole, PhD, Cindy Lau, MPH, Rinku Sutradhar, PhD, Chenthila Nagamuthu, MPH, Paul Nathan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4749.
https://doi.org/10.1182/blood-2019-130145
Published: 2019
Journal Articles

Second Cancers in Adults with Acute Promyelocytic Leukemia (APL) Treated with or without Arsenic Trioxide (ATO): A SEER-Medicare Analysis

Free
Kelly J. Norsworthy, MD, Steven T. Bird, PhD PharmD, MS, Armen Avagyan, MS, Yuchen Li, MS, Sandia Akhtar, BS, Jiemin Liao, MA, Michael Wernecke, BA, Albert B. Deisseroth, MD PhD, Meredith Chuk, MD, Thomas E. MaCurdy, PhD, Richard Swain, PhD, Jeffrey A. Kelman, MD MMSc, Ann T. Farrell, MD, Richard Pazdur, MD, Gideon Blumenthal, MD, David J. Graham, MD MPH
Journal: Blood
Blood (2019) 134 (Supplement_1): 3497.
https://doi.org/10.1182/blood-2019-130295
Published: 2019
Journal Articles

Primary and Secondary Hematological Neoplasms - Are They Related?

Free
Claudia Haferlach, MD, Constance Baer, PhD, Stephan Hutter, PhD, Anna Stengel, PhD, Niroshan Nadarajah, Wencke Walter, PhD, Manja Meggendorfer, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1702.
https://doi.org/10.1182/blood-2019-126585
Published: 2019
Journal Articles

ATM Germline Variant Increases the Risk of MPN Progression

Free
Theodoros Karantanos, MD PhD, Shruti Chaturvedi, MBBS, MS, Christopher D Gocke, MD, Donna Marie Williams, PhD, Alison R. Moliterno, MD, Evan M Braunstein, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 835.
https://doi.org/10.1182/blood-2019-125362
Published: 2019
Journal Articles

French National Retrospective Cohort of Hairy-Cell Leukemias: Risk of Second Malignancies after 10 Years of Follow-up

Free
Jérôme Paillassa, MD, Edouard Cornet, MD, Stephanie Noel, Cecile Tomowiak, Aline Schmidt, MD, Stephane Lepretre, Sandrine Vaudaux, Jehan Dupuis, MD, Alain Devidas, MD, Joly Bertrand, MD, Charlotte Petitditdier, MD, Stéphanie Haiat, Clara Mariette, MD, Catherine Thieblemont, MD PhD, Didier Decaudin, Bernard Drenou, MD, Jean Claude Eisenmann, MD, Mario Ojeda, MD, Agnès Olivrie, MD, Marie-Pierre Gourin, Olivier Lambotte, Olivier Hermine, MD PhD, Jean Michel Karsenti, MD, Pierre Feugier, MD PhD, Willy Vaillant, Jean Gutnecht, MD, Eric Lippert, MD PhD, Fabienne Huysman, MD, Kamel Ghomari, Marouane Boubaya, PhD, Vincent Levy, MD PhD, Jérémie Riou, PhD, Gandhi Damaj, MD PhD, Mathilde Hunault, MD PhD, Xavier Troussard, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1537.
https://doi.org/10.1182/blood-2019-127560
Published: 2019
Journal Articles

Outcomes of Total Body Irradiation- Versus Chemotherapy-Based Myeloablative Conditioning Regimen in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide for Acute Myelogenous Leukemia: ALWP of the EBMT Study

Free
Bhagirathbhai Dholaria, MBBS, Myriam Labopin, MD, Emanuele Angelucci, MD, Fabio Ciceri, MD, José Luis Díez-Martín, MD PhD, Benedetto Bruno, MD, Simona Sica, MD, Yener Koc, MD, Zafer Gulbas, MD, Christoph Schmid, MD, Didier Blaise, MD PhD, Angelo Michele Carella, Giuseppe Visani, Bipin N. Savani, MD, Arnon Nagler, MD MSc, Mohamad Mohty, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4584.
https://doi.org/10.1182/blood-2019-122279
Published: 2019
Journal Articles

Late Effects in Survivors of Infant Acute Lymphoblastic Leukemia from the 3 Consecutive Japanese Nationwide Clinical Trials

Free
Yuki Aoki, Akira Hayakawa, MD PhD, Kazutoshi Koike, MD PhD, Hisamichi Tauchi, MD PhD, Eiichi Ishii, MD PhD, Katsuyoshi Koh, MD, Takako Miyamura, MD PhD, Yasushi Ishida, MD PhD, Akiko Kada, MPH, Akiko M Saito, MD PhD, Atsushi Manabe, MD PhD, Keizo Horibe, MD PhD, Shuki Mizutani, MD PhD, Miho Maeda, MD, Daisuke Tomizawa, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4559.
https://doi.org/10.1182/blood-2019-123881
Published: 2019
Journal Articles

Lenalidomide and Rituximab Maintenance Therapy after Front-Line Induction Chemoimmunotherapy in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Free
Julie E Chang, MD, Vaishalee P. Kenkre, MD, Christopher D. Fletcher, MD, Aric C. Hall, MD, Natalie Scott Callander, MD, Kyungmann Kim, PhD, Grace Yi Chen, Kaitlin Chambers
Journal: Blood
Blood (2019) 134 (Supplement_1): 5470.
https://doi.org/10.1182/blood-2019-124489
Published: 2019
Journal Articles

Incidence and Risk Factors of Second Malignancies Among Medicare Beneficiaries with Newly-Diagnosed Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms Receiving Cytoreductive Therapy with Hydroxyurea

Free
Rong Wang, PhD, Rory M Shallis, MD, Scott F. Huntington, MD MPH, Amer M. Zeidan, MBBS, MHS, Steven D. Gore, MD, Amy J Davidoff, PhD MS, Xiaomei Ma, PhD, Nikolai A. Podoltsev, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 330.
https://doi.org/10.1182/blood-2019-127568
Published: 2019
Journal Articles

Impact of Competing Treatment Scenarios on Lifetime Disease Burden and Quality Adjusted Life Expectancy (QALE) Among Survivors of High-Risk Childhood Hodgkin Lymphoma (HR-HL): A Modeling Study Based on the St. Jude Lifetime (SJLIFE) Cohort

Free
Nickhill Bhakta, Kalatu Davies, PhD, Jesse Turner, PhD, Yichen Chen, PhD, Jaime Flerlage, MD MS, I-Chan Huang, PhD, Melissa M. Hudson, MD, John T. Lucas, Jr., MD MS, Monika Metzger, MD, Leslie L. Robison, PhD, F. Lennie Wong, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 267.
https://doi.org/10.1182/blood-2019-124907
Published: 2019
Journal Articles

Radioimmunotherapy for Mantle Cell Lymphoma: 5-Year Follow-up of 90 Patients from the International RIT-Registry

Free
Karin Hohloch, Christine Windemuth-Kieselbach, Pier Luigi Zinzani, MD PhD, Roberto E. Cacchione, MD, Wojciech Jurczak, MD PhD, Cheolwon Suh, Lorenz Truemper, MD, Christian W Scholz
Journal: Blood
Blood (2019) 134 (Supplement_1): 5263.
https://doi.org/10.1182/blood-2019-124192
Published: 2019
Journal Articles

Implementation of a Cardio Oncology Protocol in Uruguay

Free
Pía Oldan, MD, Andreina Gomez, MD, Gabriel Parma, MD, Cecilia Guillermo, MD, Lilián Díaz, MD, Matilde Boada, MD MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 5888.
https://doi.org/10.1182/blood-2019-127068
Published: 2019
Journal Articles

Dose-Intensification in Early Unfavorable Hodgkin Lymphoma: Long-Term Follow up of the German Hodgkin Study Group (GHSG) HD14 Trial

Free
Sarah Gillessen, MD, Annette Plütschow, Michael Fuchs, MD, Jana Markova, MD, Richard Greil, MD, Max S. Topp, MD, Julia Meissner, MD, Josée M Zijlstra, MD PhD, Dennis A. Eichenauer, Volker Diehl, MD, Peter Borchmann, MD PhD, Andreas Engert, MD, Bastian von Tresckow, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 129.
https://doi.org/10.1182/blood-2019-125249
Published: 2019